TXG News and Press, 10x Genomics Inc. From 04/18/24

A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 50.1% to $0.1783 on volume of 599,794,977 shares WiSA Technologies Inc. (WISA) rose 248.6% to $6.1 on volume of 197,912,579 shares PROSHARES TRUST (SQQQ) rose 0.0% to $11.44 on volume of 182,001,060 shar...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 37.1% to $0.1629 on volume of 102,747,129 shares WiSA Technologies Inc. (WISA) rose 69.1% to $2.96 on volume of 24,734,833 shares Peraso Inc. (PRSO) rose 37.0% to $1.7393 on volume of 23,546,162 shares ...

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 PR Newswire PLEASANTON, Calif. , April 10, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...

2024-04-10 07:00:04 ET Luke Sergott from Barclays issued a price target of $45.00 for TXG on 2024-04-10 05:45:00. The adjusted price target was set to $45.00. At the time of the announcement, TXG was trading at $37.37. The overall price target consensus is at $50.00 with...

2024-04-05 14:32:16 ET More on Markets AllianceBernstein spotlights demand shifts in the EV industry We're seeing new money come into Bitcoin – TD Securities Treasury yields continue to climb, see what SA analysts have to say AllianceBernstein warns of...

10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay PR Newswire Began global shipments for Visium HD, a new product that enables whole transcriptome spatial discovery at single cell–scale resolution PLEASANTON, Calif. , March 26,...

10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel PR Newswire Begins commercial shipments of Xenium Cell Segmentation Kit to improve determination of cell boundaries Launches first Xenium application-focused pan...

2024-03-20 04:33:40 ET Summary Cytek Biosciences is a leading cellular analysis instrument maker with a focus on the Aurora flow cytometry platform. Despite a downturn in the healthcare market, Cytek has maintained revenue growth above 15% since IPO. Cytek's technological adva...

2024-03-13 16:55:22 ET More on 10x Genomics 10x Genomics, Inc. (TXG) Q4 2023 Earnings Call Transcript Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO 10x Genomics: Still Waiting For Entry 10x Genomics GAAP EPS of -$0.41 misses by $0.0...